Request for Covid-19 Impact Assessment of this Report
MARKET DYNAMICS
MARKET DRIVERS:
--> The surge in number of working mothers.
--> Rising birth rates.
--> Technological innovation in the packaging of infant nutrition products.
--> Rising disposable incomes.
MARKET RESTRAINTS:
--> Risk of allergies due to the products.
--> Steadfast belief in conventional infant nutrition products.
--> High production costs.
MARKET SEGMENTATION:
The global infant nutrition market can be segmented on the basis of:
1. PRODUCT TYPE: starting milk formula, follow-on milk formula, toddler's milk formula, special milk formula. The starting milk formula has had the highest share of the market in terms of value up until 2016 and is expected to continue its dominance in the forecast period. The follow-on milk formula has been predicted to grow at the highest rate during the forecast period.
2. DISTRIBUTION CHANNEL: Supermarkets, online stores, specialty stores, pharmacy and others. The pharmacy stores hold the highest share of the market value. It is expected that the supermarket share will grow at the highest rate in the forecast period due to the increasing number of supermarkets in developing countries. With companies like Walmart and Kroger opening up supermarkets in developing countries by the day, the prediction is close to realization.
GEOGRAPHICAL ANALYSIS:
Geographically, the market is segmented into Europe, Asia-Pacific, Latin America, North America,and the Middle East and Africa.
--> ASIA-PACIFIC: This region is expected to experience the highest growth rate during the forecast period. Growth in the working women population due to decreased social stigma has also fueled growth due to the convenience offered. Most importantly, it is the most populated region and with high child birth rate.
--> EUROPE: Although this region is expected to hold the highest market share in terms of value, the growth of this region is expected to show a drop due to decreasing birth rates.
KEY PLAYERS:
--> Nestle.
--> Abbot Laboratories.
--> Danone.
--> Mead Johnson.
--> Kraft Heinz
Report Contents:
> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players
Regional Analysis:
> North America
>> US and Canada
> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.
Report Highlights:
> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...